A new oral medication for type two diabetes is now available in Australia. The drug, Januvia, is designed to manage the nation’s fastest growing chronic disease in a better way, with which millions of Australians are suffering. Given a single dose a day, “Januvia boosts the effect of a natural body process called the incretin system”, Sydney’s Royal North Shore Hospital, Greg Fulcher said in a statement. Incretins are intestinal hormones that are released after the intake of food. They are essential for regulating blood glucose. Type two diabetes patients have impaired incretins. The drug, the first ever oral medication for the purpose, is a Merck & Co product.